TNF and inflammatory bowel disease: Conversely, Zanoli et al. conducted a small-sized longitudinal study on 32 IBD subjects; 14 were treated with only 5-ASA, 11 were treated with CS and azathioprine, and seven were treated with TNF-α, as opposed to 30 matched controls.